Severity of liver disease in hepatitis C infection contracted through injecting drug use

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 6, 1999, Pages 776-781

  Ostapowicz, G ^a   Bell, S J ^a   Desmond, P V ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Alcohol; Cirrhosis; Hepatitis C; Injecting drug use

Indexed keywords

AMPHETAMINE; DIAMORPHINE;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INJECTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; SEROLOGY; VIRUS TRANSMISSION;

EID: 0033403165     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00779.x     Document Type: Article

References (24)

1. 1. Wodak A. Hepatitis C: waiting for the grim reaper. Med J Aust 1997; 166: 284-5.
2. 2. Strasser SI, Watson KJR, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 1995; 162: 355-8.
3. 3. Sladden TJ, Hickey AR, Dunn TM, Beard JR. Hepatitis C transmission on the north coast of New South Wales: explaining the unexplained. Med J Aust 1997; 166: 290-3.
4. 4. Whyte GS, Savoia HF. The risk of transmitting HCV, HBV, or HIV by blood transfusion in Victoria. Med J Aust 1997; 166: 584-6.
5. 5. Bell J, Batey R, Farrell G, Crewe E, Cunningham A, Byth K. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274-6.
6. 6. Fairley CK, Leslie DE, Nicholson S, Gust ID. Epidemiology and hepatitis C virus in Victoria. Med J Aust 1990; 153: 271-3.
7. 7. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-41.
8. 8. Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust 1997, 167: 17-20.
9. 9. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
10. 10. Seeff LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906-11.
11. 11. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-74.
12. 12. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993; 119: 110-5.
13. 13. Poynard T, Bedossa P, Opolon P et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
14. 14. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients. Hepatology 1997; 26: 485-90.
15. 15. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-4.
16. 16. Ostapowicz G, Watson KJR, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998; 27: 1730-5.
17. 17. Isopet J, Bogard M, Costes J et al. Multicentre evaluation of analytical performances of the Amplicor HCV RNA qualitative test. Hepatology 1994; 20 (Suppl.): 241A.
18. 18. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-102.
19. 19. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
20. 20. Crofts N, Jolley D, Kaldor J. The epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epi Comm Health 1997; 51: 692-7.
21. 21. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
22. 22. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.
23. 23. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211-5.
24. 24. Romeo R, Colombo M, Rumi M et al. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996; 3: 183-90